Patriot Financial Group Insurance Agency’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Other funds holding DNLI
CM
AVM
FP
Patriot Financial Group Insurance Agency's DNLI Position: Q3 2022 in Review
Patriot Financial Group Insurance Agency sold out of Denali Therapeutics (DNLI) in Q3 2022, closing a stake of 800 shares — an estimated $24K sold.
Patriot Financial Group Insurance Agency first reported a position in DNLI in Q1 2018 and held it in 18 quarters. The position peaked at $967K in Q3 2018. 200 funds tracked by Wall St. Rank hold DNLI as of Q3 2022.
- Patriot Financial Group Insurance Agency reported no remaining Denali Therapeutics position as of Q3 2022 after selling out during the quarter.
- Patriot Financial Group Insurance Agency sold 800 Denali Therapeutics shares in Q3 2022, an estimated $24K.
- Patriot Financial Group Insurance Agency first reported a position in Denali Therapeutics in Q1 2018 and held it in 18 quarters.
- Patriot Financial Group Insurance Agency's Denali Therapeutics position peaked at $967K in Q3 2018.
- 200 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2022.
Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.